CHO Cells clinical trials
How each study uses CHO Cells is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the CHO Cells studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Recombinant novel coronavirus vaccine (CHO cells)
- 5
- Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells)
- 3
- Recombinant novel coronavirus protein vaccine (CHO cells)
- 3
- Low dose Recombinant Herpes Zoster Vaccine (CHO cells)
- 2
- High dose Recombinant Herpes Zoster Vaccine (CHO cells)
- 2
Studies by the year they started
15 studies that test it; most in 2022 (4)
| Year | Studies |
|---|---|
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 4 |
| 2023 | 4 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 15 · Other 0
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. (12) · MAXVAX Biotechnology Limited Liability Company (3)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses CHO Cells is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 15
- Clinical Study of Omicron BA.4/5-Delta Strain Recombinant Novel Coronavirus Protein Vaccine (CHO Cells)Not yet recruitingNot applicableAnhui Zhifei Longcom Biologic Pharmacy Co., Ltd.NCT06025812Written as Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells)How we know
- Immunogenicity and Safety of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy Subjects Aged 30 Years and AboveCompletedPhase 2MAXVAX Biotechnology Limited Liability CompanyNCT05856084Written as Low dose Recombinant Herpes Zoster Vaccine (CHO cells)How we know
- Safety and Immunogenicity of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy Subjects Aged 18 Years and AboveCompletedPhase 1MAXVAX Biotechnology Limited Liability CompanyNCT05636436Written as Low Dose Recombinant Herpes Zoster Vaccine (CHO cells)How we know
- Safety and Immunogenicity of Recombinant RSV Vaccine (CHO Cell) in Healthy Subjects Aged 18 Years and AboveActive, not recruitingPhase 1/2MAXVAX Biotechnology Limited Liability CompanyNCT06642558Written as Recombinant Respiratory Syncytial Virus Vaccine (CHO Cells)(low dose)How we know
- Omicron BA.4/5-Delta Strain Recombinant Novel Coronavirus Protein Vaccine (CHO Cells)CompletedNot applicableAnhui Zhifei Longcom Biologic Pharmacy Co., Ltd.NCT05850507Written as Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells)How we know
- Omicron BA.4/5-Delta COVID-19 Vaccine Phase I Clinical TrialStatus unknownPhase 1Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.NCT06043388Written as Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells)How we know
- Immunogenicity and Safety of Booster Immunization of ZF2001 After Inoculation With Two Doses of CoronaVacCompletedPhase 1/2Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.NCT05205096Written as Recombinant novel coronavirus vaccine (CHO cells)How we know
- ZF2001 Booster Immunization Clinical Trials of 6 Months After the Completion of Basic ImmunizationCompletedPhase 1/2Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.NCT05198063Written as Recombinant novel coronavirus vaccine (CHO cells)How we know
- To Evaluate the Immunogenicity and Safety of Sequential Booster Immunization of Recombinant Novel Coronavirus Vaccine (CHO Cells) for SARS-CoV-2CompletedNot applicableAnhui Zhifei Longcom Biologic Pharmacy Co., Ltd.NCT05895110Written as Recombinant Novel Coronavirus vaccine (CHO Cells)How we know
- A Trial Evaluate the Immunogenicity and Safety of Recombinant COVID-19 Omicron-Delta Variant Vaccine (CHO Cell)Status unknownPhase 3Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.NCT05616754Written as Omicron-Delta Recombinant Novel Coronavirus Protein Vaccine (CHO cells)How we know
- ZF2001 Booster Immunization Clinical Trials of 12 Months After the Completion of Basic ImmunizationCompletedPhase 1/2Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.NCT05198102Written as Recombinant novel coronavirus vaccine (CHO cells)How we know
- Immunogenicity and Safety of Booster Immunization of ZF2001 After Inoculation With Two Doses of BBIBP-CorVStatus unknownPhase 1/2Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.NCT05205083Written as Recombinant novel coronavirus vaccine (CHO cells)How we know
- Recombinant New Coronavirus Vaccine (CHO Cells) to Prevent SARS-CoV-2 Phase I Clinical Trial (≥60 Years Old)Status unknownPhase 1Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.NCT04550351Written as Biological/Vaccine: Recombinant new coronavirus vaccine (CHO cells) high-dose groupHow we know
- Phase I Clinical Study of Recombinant Novel Coronavirus VaccineStatus unknownPhase 1Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.NCT04445194Written as Recombinant new coronavirus vaccine (CHO cells) high-dose groupHow we know
- Clinical Study of Recombinant Novel Coronavirus VaccineStatus unknownPhase 2Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.NCT04466085Written as Recombinant new coronavirus vaccine (CHO cells) high-dose groupHow we know